Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

most likely drawn from the glucagon-like peptide 1 class of drugs. As I wrote in my last note on Structure: The most famous examples of GLP-1 agonist drugs are Novo Nordisk's (NVO) semaglutide ...

according to the Centers for Disease Control and Prevention (CDC), the weight loss drug known as semaglutide has become more popular. This medication is a glucagon-like peptide-1 (GLP-1 ...

Semaglutide shows promise in reducing alcohol cravings and consumption. Could it be a future treatment for AUD?

Semaglutide mimics the action of the natural protein glucagon-like peptide 1 ... meaning its molecules mimic the structure of GLP-1, binding to its receptor like a counterfeit key someone ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2D). Current ...

For its part, the FDA said it "has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved." The agency will continue to allow ...

Direct-to-consumer telehealth company Hims & Hers is forging ahead in the aftermath of the semaglutide shortage ... compounded versions of glucagon-like peptide-1 agonist weight loss medications.

Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a ...